{"count": 2, "results": [{"_id": "36457559", "pmid": 36457559, "pmcid": "PMC9705576", "title": "Diabetes duration and types of diabetes treatment in data-driven clusters of patients with diabetes", "journal": "Front Endocrinol (Lausanne)", "authors": ["Zhang J", "Deng Y", "Wan Y", "Wang J", "Xu J"], "date": "2022-11-15T00:00:00Z", "doi": "10.3389/fendo.2022.994836", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "994836", "score": 50267.63, "text_hl": "Among the non-@GENE_INS @GENE_3630 @@@insulin@@@ hypoglycemic drug options, @DISEASE_Pseudoacromegaly_with_Severe_Insulin_Resistance @DISEASE_MESH:C566531 @@@SIRD@@@ had higher rates of receiving @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, @GENE_SI @GENE_6476 @@@alpha-glucosidase@@@ inhibitor (AGI), and @GENE_GCG @GENE_2641 @@@glucagon-like peptide-1@@@ drug; the @<m>DISEASE_Maturity_Onset_Diabetes_of_the_Young_Type_1</m> @DISEASE_MESH:C565101 @@@MOD@@@ and @<m>DISEASE_Maturity_Onset_Diabetes_of_the_Young_Type_1</m> @DISEASE_MESH:C565101 @@@MARD@@@ groups both received @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, AGI and sodium-glucose cotransporter 2 inhibitor (SGLT-2i) drug ratio was higher. ", "citations": {"NLM": "Zhang J, Deng Y, Wan Y, Wang J, Xu J. Diabetes duration and types of diabetes treatment in data-driven clusters of patients with diabetes Front Endocrinol (Lausanne). 2022;13():994836. PMID: 36457559", "BibTeX": "@article{36457559, title={Diabetes duration and types of diabetes treatment in data-driven clusters of patients with diabetes}, author={Zhang J and Deng Y and Wan Y and Wang J and Xu J}, journal={Front Endocrinol (Lausanne)}, volume={13}, pages={994836}}"}}, {"_id": "37711893", "pmid": 37711893, "pmcid": "PMC10498112", "title": "Identification and precision therapy for three maturity-onset diabetes of the young (MODY) families caused by mutations in the HNF4A gene", "journal": "Front Endocrinol (Lausanne)", "authors": ["Zhang J", "Jiang Y", "Li J", "Zou H", "Yin L", "Yang Y", "Yang L"], "date": "2023-08-29T00:00:00Z", "doi": "10.3389/fendo.2023.1237553", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1237553", "score": 50235.598, "text_hl": "Proband B responded well to @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ combined with diet therapy because of his higher body mass index (BMI). ", "citations": {"NLM": "Zhang J, Jiang Y, Li J, Zou H, Yin L, Yang Y, Yang L. Identification and precision therapy for three maturity-onset diabetes of the young (MODY) families caused by mutations in the HNF4A gene Front Endocrinol (Lausanne). 2023;14():1237553. PMID: 37711893", "BibTeX": "@article{37711893, title={Identification and precision therapy for three maturity-onset diabetes of the young (MODY) families caused by mutations in the HNF4A gene}, author={Zhang J and Jiang Y and Li J and Zou H and Yin L and Yang Y and Yang L}, journal={Front Endocrinol (Lausanne)}, volume={14}, pages={1237553}}"}}]}